The European Commission (EC) on Friday authorized the use of Pfizer’s COVID-19 antiviral pill one day after the European Unions’ (EU) drugs regulator backed the treatment for adults who do not require supplemental oxygen and who are at increased risk of severe disease.
Stella Kyriakides, the EU’s commissioner for health and food safety, called it “a key step in bringing the most promising therapeutics to citizens and a strong, second line of defense against the pandemic after vaccination.”
